The researchers applied single-cell RNA sequencing technology to dissect thousands of individual mammary epithelial cells from aged female mice that had either experienced an early first pregnancy or remained nulliparous (never pregnant). This approach allowed unprecedented resolution in characterizing cellular heterogeneity and gene expression dynamics within the aging mammary gland, providing critical insights into lineage commitment and cellular identity. Their analysis exposed a previously unrecognized subset of “hybrid” epithelial cells in aged, nulliparous mice. These cells defy normal classification by simultaneously expressing markers of both luminal and basal mammary lineages, suggesting a breakdown in cellular differentiation fidelity—a phenomenon now linked with increased tumor risk.

A central molecular player surfaced from this study: Interleukin-33 (IL-33), an inflammatory cytokine markedly elevated in the hybrid cell population. IL-33 not only serves as a biomarker for these confused cells but also actively drives features reminiscent of early tumorigenesis. When young mammary epithelial cells were experimentally exposed to IL-33 in vitro, they exhibited enhanced proliferative capacity and formed organoids more readily, especially in the absence of functional Trp53, a crucial tumor suppressor gene. This finding implicates IL-33 as a potent inducer of cellular plasticity and proliferation, likely fostering a microenvironment conducive to malignant transformation.

Intriguingly, early pregnancy appears to act as a “cellular reset button,” preventing the emergence and accumulation of these IL-33–positive hybrid populations during mammary aging. The process seems to enforce a stringent lineage integrity, compelling cells to commit to their specialized roles and maintaining tissue homeostasis. This mechanism provides a biological rationale for the long-observed protective effect of early childbirth, which may only manifest decades later despite occurring much earlier in life. By stabilizing cell identity and suppressing pro-tumorigenic signals, pregnancy effectively rewires the mammary gland’s aging process.

The implications of these findings are profound when contextualizing breast cancer epidemiology. Most breast cancer cases are diagnosed post-menopause, a stage mimicked here by studying aged mice beyond reproductive years. Yet the protective influence of a pregnancy decades earlier reprograms the aging breast at the molecular and cellular levels, highlighting the significance of early reproductive history in modulating cancer risk. This delayed effect reflects the slow accrual of cellular abnormalities that pregnancy helps to mitigate, an insight that fundamentally advances our understanding of breast tissue aging and oncogenesis.

Further analysis revealed that pregnancy restored the balance between basal and luminal mammary epithelial cells, which otherwise becomes skewed with aging. Typically, basal cells expand disproportionately in aged nulliparous mice, a shift reversed by parity. Functional assays demonstrated that both basal and luminal cells from aged parous animals formed fewer organoids, indicative of reduced proliferative potential and possibly a lowered risk of malignant transformation. Moreover, luminal cells in parous mice retained molecular hallmarks of post-pregnancy involution—a state known to stimulate immune surveillance—suggesting an additional cancer-protective mechanism actively engaging the immune system.

The discovery of IL-33’s role in fostering hybrid epithelial cells elucidates a key link between inflammation, cellular plasticity, and oncogenesis within the breast. Inflammatory signaling has long been implicated in tumor biology, but this study places IL-33 at a central crossroads, mediating age-dependent cellular confusion that might initiate carcinogenesis. By experimentally exposing cells to IL-33 and suppressing Trp53, the researchers recreated conditions facilitating early tumor development, underscoring how aging and inflammatory pathways converge to drive malignant progression.

While this study was performed in mice, the authors emphasize the conserved architecture of mammary glands and analogous epidemiological patterns of breast cancer risk in humans, suggesting translational relevance. The elucidation of hybrid cell populations and their regulation by pregnancy offers novel targets for preventative strategies, potentially transforming how at-risk women are monitored or treated. Interventions that mimic pregnancy’s stabilizing influence on mammary cells or therapeutically modulate IL-33 signaling could emerge as innovative means to forestall breast cancer.

Although definitive proof connecting hybrid cells to cancer formation in humans is pending, the identification of this cell population as a biomarker and functional contributor to tumorigenic processes marks a significant advance. The researchers plan to delve deeper into the biology and regulation of these cells, aiming to unravel how lineage instability evolves and whether it directly precipitates malignancy. Their future work may also explore how immune mechanisms interact with cellular identity programs during mammary aging.

Ultimately, this study reframes the narrative around pregnancy and breast cancer by highlighting pregnancy not merely as a reproductive milestone but as a powerful biological modulator that permanently affects cellular aging trajectories. The protective legacy of early pregnancy reflects a profound reprogramming of mammary gland biology, emphasizing the interplay between developmental history and cancer susceptibility. These insights open avenues for novel diagnostic and therapeutic approaches focused on maintaining cellular fidelity and quelling inflammatory drivers in the aging breast.

This research was led by Shaheen Sikandar, an assistant professor at UC Santa Cruz’s Department of Molecular, Cell, and Developmental Biology. Co-authors included Paloma Medina, Veronica Haro Acosta, Sara Kaushik, and Matijs Dijkgraaf, all of whom contributed to the interdisciplinary effort involving genomics, stem cell biology, and molecular oncology. Funded by the Hellman Foundation and NIH’s National Cancer Institute fellowship program, this work propels the field toward a nuanced understanding of cancer risk shaped by lifelong biological processes.

For decades, breast cancer has posed a complex puzzle, where age and reproductive history intersect to influence disease onset. The elucidation of IL-33+ hybrid epithelial cells and their suppression through early pregnancy provides a transformative framework to conceptualize breast tissue aging and cancer prevention. As the scientific community builds upon these findings, hope emerges for tailored interventions that replicate pregnancy’s protective effects, dramatically altering breast cancer trajectories and improving outcomes worldwide.

Subject of Research: Animals

Article Title: Divergent aging of nulliparous and parous mammary glands reveals IL33+ hybrid epithelial cells

News Publication Date: 21-Jan-2026

Web References:
DOI link

Image Credits: Sikandar Lab / UC Santa Cruz

Keywords: breast cancer, aging, mammary gland, pregnancy, IL-33, hybrid epithelial cells, cell differentiation, inflammation, single-cell RNA sequencing, tumor suppression, Trp53, cellular plasticity

The innate immune system is our body’s first line of defense, an ancient and rapid-response mechanism designed to combat invading pathogens such as viruses and bacteria. This system relies on specialized proteins capable of recognizing microbial components and triggering defensive responses. Halfmann’s lab has uncovered that many of these proteins possess a peculiar structural feature known as the “death fold domain,” which drives the rapid and highly specific assembly of proteins into three-dimensional puzzle-like formations. These structures act as molecular switches, amplifying immune signals and initiating programmed cell death to restrict pathogen spread. This discovery shifts the paradigm, framing these protein assemblies as critical “batteries” that store and release energy to power immune responses.

The heart of this mechanism lies in the exquisite supersaturation of death fold proteins within cells. Rather than existing at equilibrium, these proteins are present in quantities that far exceed their solubility, placing the cellular milieu in a metastable state akin to a charged battery waiting to be discharged. Upon detection of a pathogen-derived molecular template, these supersaturated proteins rapidly coalesce into robust assemblies. This phase transition is both irreversible and highly cooperative, creating an all-or-none response that culminates in cell death and inflammation. Through state-of-the-art single-cell assays and innovative yeast model systems, the Halfmann team characterized over 100 human proteins harboring death fold domains, revealing a subset that function as these protein-phase batteries.

Intriguingly, the process that works so effectively to protect youth has an inadvertent downside. Molecular stochasticity over time introduces a risk of spontaneous, signal-independent assembly of these death fold proteins. As cells age, even in the absence of pathogens, random fluctuations can trigger puzzle formation, setting off cell death and inflammatory cascades without external provocation. This phenomenon embodies a biological “Catch-22″—the very machinery that safeguards us early in life predisposes us to chronic inflammation and tissue damage as we grow older. “We are essentially trading the certainty of survival in youth for the inevitability of aging-related degeneration,” explains Halfmann.

From a biophysical perspective, the architecture of the death fold domain enables extremely tight and selective protein-protein interactions. These domains manage to avoid accidental self-assembly through intricate folding trajectories and folding pathways that require precise molecular templates to nucleate the process. The phenomenon is reminiscent of prion-like dynamics but is functionally tuned to trigger an immune alarm rather than pathological aggregation. This molecular precision underscores the evolutionary balance struck between responsiveness and safety, enabling swift immune activation with limited false alarms—until the fidelity erodes with age.

This research not only elucidates the biochemical basis of programmed cellular demise but also offers a compelling explanation for the onset of chronic inflammatory diseases in the elderly. Many conditions previously attributed only to external insults or genetic predispositions may actually originate from intrinsic protein phase transitions within cells. If these puzzle-like assemblies could be pharmacologically modulated—either by reducing the cellular concentration of susceptible proteins or altering their folding trajectories—there lies potential to attenuate inflammaging and its downstream pathologies.

Nonetheless, the therapeutic implications present a delicate balancing act. Damping these immune batteries could inadvertently blunt necessary infection responses, heightening susceptibility to pathogens. “It’s a complex risk-benefit landscape,” notes Alex Rodríguez Gama, Ph.D., lead author of the study, “but for certain patient populations, especially those enduring chronic inflammatory diseases, accepting that tradeoff could prove transformational.” The possibility of decelerating diseases like Alzheimer’s and Parkinson’s through targeted modulation of innate immune protein assemblies sparks a new frontier in biomedical research.

Technically, the team employed an array of experimental approaches including advanced fluorescence microscopy, quantitative phase separation assays, and yeast genetics to demonstrate the supersaturation property and nucleation behavior of death fold proteins. Their multidisciplinary methodology provided unprecedented insights into protein folding kinetics in living cells, revealing how subtle shifts in cellular environments and protein concentrations can tip the balance toward pathological inflammation. This innovative research framework may catalyze further investigation into phase separation phenomena across biological systems.

Beyond elucidating aging mechanisms, this work accentuates the evolutionary logic embedded in our immune system architecture. The concept of protein phase change batteries exemplifies a strategic use of biophysical properties to achieve rapid cellular decision-making. Cells are equipped with energy reservoirs encoded in their proteome, allowing instantaneous activation of lethal inflammation upon detecting a microscopic microbial footprint. The elegance of this system reflects a sophisticated evolutionary optimization where speed and robustness predominate, albeit with a late-life cost.

Importantly, the study sets the stage for a new class of biomedical interventions targeting protein phase transitions as therapeutic nodes. Modulators that stabilize or destabilize protein conformations involved in death fold assembly could emerge as next-generation drugs to manage immune disorders and age-related inflammatory diseases. By bridging molecular biophysics with immunology and gerontology, the research pioneers a holistic understanding of how protein dynamics shape healthspan and longevity.

In conclusion, the discovery of supersaturation-driven protein assemblies as innate immune batteries reshapes our comprehension of inflammation and aging. It reveals a hitherto unappreciated tradeoff encoded in molecular structures fostered by evolutionary pressures: immediate protection against infectious disease versus the gradual ignition of chronic inflammation underpinning aging pathologies. This revelation paves the way for innovative strategies aimed at extending healthy lifespan by finely tuning our cellular “puzzle pieces” to mitigate the molecular ‘spark’ that lights the inflammatory fire.

Subject of Research: Not applicable

Article Title: Protein phase change batteries drive innate immune signaling and cell fate

News Publication Date: 16-Sep-2025

Web References:

• Stowers Institute for Medical Research: http://www.stowers.org/
• Halfmann Lab: https://www.stowers.org/labs/halfmann-lab
• Original Study in eLife: https://doi.org/10.7554/eLife.107962.1

References:

• Halfmann, R., Rodríguez Gama, A., et al. (2025). Protein phase change batteries drive innate immune signaling and cell fate. eLife. https://doi.org/10.7554/eLife.107962.1

Image Credits: Stowers Institute for Medical Research

Keywords: Inflammation, Aging, Immune system, Innate immune system, Protein folding, Protein phase separation, Cell death, Neurodegenerative diseases, Alzheimer’s, Parkinson’s, Cancer, Molecular neuroscience

Fundamentally, ageing involves a progressive decline in the body’s intrinsic ability to regulate and repair cellular functions. Over time, various checkpoints that oversee genomic integrity, protein homeostasis, and metabolic balance begin to falter. This gradual erosion of cellular maintenance systems precipitates dysfunctions such as impaired DNA repair capacity and disrupted intercellular signaling. The cumulative effect is the increased likelihood of pathologies such as oncogenesis and vascular degeneration. Current clinical practice primarily addresses these conditions as isolated phenomena; however, by focusing on ageing itself, medical science could develop interventions that preempt these diseases by maintaining cellular homeostasis and resilience throughout the ageing process.

One of the most compelling proposals put forth by the Leopoldina paper is the establishment of a multidisciplinary systems ageing consortium within Germany. This consortium would synergize expertise spanning molecular biology, systems biology, bioinformatics, and clinical gerontology. By integrating data derived from model organisms—such as nematodes, rodents, and primates—with extensive human biospecimens and clinical datasets, this collaborative infrastructure aims to decode the systemic interplay that governs ageing. Such an integrative framework is crucial given the complex and multifactorial nature of ageing, which is influenced by genetic predispositions, environmental exposures, and lifestyle factors.

Central to advancing our understanding of ageing is the deployment of large-scale multiomics approaches. Multiomics integrates diverse biological data layers—including genomics, transcriptomics, proteomics, metabolomics, and epigenomics—to provide a holistic portrait of cellular and organismal states. Collecting and analyzing these datasets enable the identification of robust biomarkers that can quantify biological age, which often diverges significantly from chronological age due to differences in individual health trajectories. These biomarkers would serve as essential tools for assessing the efficacy of geroprotective interventions in clinical contexts, facilitating precision medicine approaches tailored to individual ageing profiles.

The paper emphasizes the urgent need for the creation of a national biological database in Germany, modeled after the British Biobank, to collate and make accessible multiomics data across populations. Such a repository would democratize data access for researchers, accelerating discoveries and innovation in geroprotection. Beyond mere data accumulation, sophisticated bioinformatics pipelines and machine learning algorithms will play a vital role in disentangling the complex biological signatures of ageing, mapping out potential targets for pharmaceutical and lifestyle interventions.

Significantly, the discourse also highlights existing medications—some commonly prescribed for conditions like hypertension and type 2 diabetes—that exhibit unexpected geroprotective effects. This pharmacoepidemiological insight stresses the importance of re-examining approved drugs under the lens of ageing biology to repurpose them for promoting healthy ageing. Advanced data analytics can identify these candidates, potentially fast-tracking new therapeutic avenues without the prolonged timelines typical of de novo drug development.

Among the most exciting frontiers discussed is cellular reprogramming, a technique rooted in induced pluripotent stem cell technology, which offers a radical strategy to reverse cellular ageing at the tissue level. By resetting epigenetic marks and restoring youthful gene expression patterns, cellular reprogramming holds promise for rejuvenating aged tissues and restoring organ function. While currently in experimental stages, the translation of these methodologies into clinical practice could revolutionize treatments for age-related dysfunctions and chronic diseases.

A critical enabler of this budding paradigm is the identification and validation of reliable biomarkers of ageing that can be utilized in everyday medical practice. These biomarkers would not only enable early detection of age-associated risk but also provide actionable insights enabling clinicians to deliver personalized advice grounded in biological evidence, thus enhancing preventative medicine. Integration of such biomarkers into general practice and hospital settings would mark a seismic shift from reactive to proactive healthcare models.

Human health ageing research presents formidable technological and ethical challenges. For instance, longitudinal studies tracking biological ageing require extensive commitment, and the interpretation of multiomic datasets demands cutting-edge computational infrastructure. Additionally, the implementation of large-scale biobanks involves navigating complex consent and privacy issues to safeguard participant data. The Leopoldina paper acknowledges these hurdles and calls for coordinated, interdisciplinary efforts to surmount them, emphasizing that the societal benefits will far outweigh the initial investments.

International collaboration remains a cornerstone of these aspirations. Building on an international workshop convened by the Leopoldina’s Focus Group Medicine in November 2024—which gathered preeminent national and international experts in geriatric medicine—this initiative exemplifies the spirit of global scientific dialogue. Pooling resources, data, and expertise across borders is essential for standardizing methodologies, validating findings, and ultimately driving innovations that can be translated into clinical benefits on a global scale.

As demographic shifts precipitate unprecedented growth in ageing populations worldwide, the healthcare systems of industrialized and developing nations alike face critical pressures from rising incidences of chronic, age-related diseases. The imperative to develop health-extending medicine extends beyond individual well-being to economic and societal sustainability. By mitigating the burden of chronic illnesses and maintaining functional independence in older adults, these strategies promise to alleviate pressures on healthcare infrastructure and social support systems.

The German National Academy of Sciences Leopoldina underscores that while policy decisions rest with democratically legitimized authorities, the scientific community’s role is to inform and guide through rigorous evidence and thoughtful recommendations. As an academy founded in 1652 and recognized as Germany’s National Academy of Sciences since 2008, the Leopoldina combines centuries of scholarly tradition with cutting-edge scientific expertise. Their proactive engagement with the ageing challenge signals a pivotal moment in how society may soon comprehend and confront the biology of ageing, heralding a new era where ageing is no longer an inevitable descent into disease but a modifiable process amenable to medical intervention.

In summary, this landmark discussion paper not only illuminates the complex biology underlying ageing but also charts a bold course for transforming medicine towards proactive, preventative approaches that target ageing itself. Through coordinated research consortia, expansive multiomics databases, drug repurposing strategies, and pioneering cellular therapies, the vision of health-extending medicine is rapidly materializing. As humanity stands on the threshold of unprecedented demographic change, embracing this paradigm shift offers hope for healthier, longer lives across the globe.

Subject of Research: Biology of ageing, geroprotection, and age-related diseases
Article Title: Health-Extending Medicine in an Aging Society – Prospects for Medical Research and Practice
News Publication Date: 2024
Web References: Leopoldina official website (exact link not provided)
Keywords: Ageing, Geriatrics, Human health, Aging populations, Biomedical policy, Human biology, Public health, Pharmaceuticals, Pharmacology, Health care, Diseases and disorders